HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.620

+0.0400.72%

Volume:5.84M

Turnover:32.89M

Market Cap:2.20B

PE:-8.75

High:5.845

Open:5.630

Low:5.450

Close:5.580

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.76

T/O Rate:1.51%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.642

ROE:-125.57%

ROA:-44.55%

PB:7.05

PE(LYR):-8.75

PS:-164.37

Loading ...

Overview Company News Filings

PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot

Bulletin Express

PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference

PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership

Bulletin Express

PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026

PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process

Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff

Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff

Movement Alert｜PegBio Pharma Intraday Decline 15.99% in Regular Trading, Lock-Up Expiry on IPO Anniversary Triggers Selling Pressure

Stock Track | PegBio Soars 18.76% Intraday on Continued GLP-1 Drug Commercialization Momentum

Movement Alert｜PegBio Rises 7.54% in Regular Trading, Rebounding After Pullback as GLP-1 Drug Commercialization Momentum Continues

Stock Track | PegBio Plummets 6.96% Intraday Amid Lock-Up Expiry Concerns Following Partnership Rally

Movement Alert｜PegBio Falls 5.14% in Regular Trading, Pullback Continues Amid Lock-Up Expiry Concerns Following Multi-Day Rally

Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals

Movement Alert｜PegBio Co Ltd Rises 8.37% in Regular Trading, Extending Gains on GLP-1 Drug Commercialization Momentum

PEGBIO CO-B Nominates Liao Yilin as Independent Non-Executive Director Candidate

Pegbio files directors list with Hong Kong Stock Exchange

PegBio: INED Resignation Triggers Temporary Rule Breach; New Candidate Nominated to Restore Compliance

Bulletin Express

PegBio independent director Fan resigns, audit committee chair role to change

Stock Track | PegBio Soars 28.96% Intraday on Exclusive GLP-1 Drug Commercialization Deal

PEGBIO CO-B (02565) Surges 150% in Late Trading Following Exclusive Commercial Deal for Padakine in Mainland China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/02565/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.62,"timestamp":1789027724005,"preClose":5.58,"halted":0,"volume":5840950,"delay":0,"changeRate":0.007168458781362013,"floatShares":386000000,"shares":391000000,"eps":-0.6422942103653517,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"09-10 16:08:44","open":5.63,"high":5.845,"low":5.45,"amount":32892209,"amplitude":0.070789,"askPrice":5.62,"askSize":13450,"bidPrice":5.615,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.9968312720257841,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.58,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.7550241658843525,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.642294,"volumeRatio":0.7550241658843525,"shares":391000000,"dividePrice":0,"high":5.845,"amplitude":0.070789,"preClose":5.58,"low":5.45,"week52Low":4.94,"pbRate":"7.05","psRate":"-164.37","week52High":77,"institutionHeld":0,"latestPrice":5.62,"committee":-0.147122,"eps":-0.6422942103653517,"divideRate":0,"volume":5840950,"delay":0,"ttmEps":-0.9968312720257841,"open":5.63,"prevYearClose":69,"prevWeekClose":5.735,"prevMonthClose":5.495,"prevQuarterClose":5.33,"fiveDayClose":5.7,"twentyDayClose":6.455,"sixtyDayClose":6.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-09-09","current":-5.630984,"percent":0.993528,"low":-87.782868,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"high":-5.557418,"avg":-42.712482,"sd":28.499314,"marketCap":2182290748},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817},{"date":"2026-09-04","current":-5.809614,"twenty":-72.647581,"median":-53.43223,"eighty":-11.296065,"marketCap":2242909936},{"date":"2026-09-09","current":-5.643565,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"marketCap":2182290748}],"updateTime":1789036849243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104725442","title":"PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot","url":"https://stock-news.laohu8.com/highlight/detail?id=1104725442","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104725442?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:43","pubTimestamp":1780324997,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B) has issued the formal proxy for its 2025 annual general meeting, to be convened at 10:00 a.m. (Hong Kong time) on 24 June 2026. The hybrid session will be physically...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154515574","title":"PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1154515574","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154515574?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:07","pubTimestamp":1780308430,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that its internally developed circular RNA-encoded GLP-1 analog, CR059, has had its research findings accepted for presentation at the 62nd European Association...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","BK4588","BK4581","BK1161","161726","02565","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150034110","title":"PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1150034110","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150034110?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:05","pubTimestamp":1780308334,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B, 02565) disclosed that its next-generation GLP-1 candidate, CR059, has been accepted for an oral discussion session at the 62nd Annual Meeting of the European...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640585689","title":"PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640585689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640585689?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:02","pubTimestamp":1780308126,"startTime":"0","endTime":"0","summary":"PegBio disclosed June 1, 2026 that preclinical findings for CR059 were accepted for EASD 2026 and selected for an oral discussion session.The results were previously selected as a late-breaking abstract for the ADA Scientific Sessions; the EASD presentation is scheduled for 2026.A single dose in non-human primates supported sustained drug exposure and prolonged body-weight reduction, suggesting potential for ultra-long-acting dosing.The program uses circular RNA to drive in-body production of a GLP-1 analogue, positioning it as a differentiated approach versus peptide GLP-1 drugs.CR059 remains in R&D, with clinical development and commercialization still uncertain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL5zKjBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194812021","title":"PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process","url":"https://stock-news.laohu8.com/highlight/detail?id=1194812021","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194812021?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:20","pubTimestamp":1779963627,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) announced that its Vepetide Injection has been included in the public notice for the second batch of 2026 reference drug pre-communication supplementary drugs, as published by the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","399441","BK1161","02565","161726","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155488745","title":"Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1155488745","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155488745?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:34","pubTimestamp":1779932097,"startTime":"0","endTime":"0","summary":"PegBio Pharma's stock soared 15.53% during intraday trading on Thursday, marking a significant recovery in its share price.The sharp rise represents a technical rebound following a steep selloff in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111038713","title":"Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1111038713","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111038713?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:32","pubTimestamp":1779931937,"startTime":"0","endTime":"0","summary":"On May 28, PegBio Pharma (02565.HK) rose 10.77% in regular trading, trading at HK$10.1/share, with trading volume of HK$35.96 million.On the news front, the stock experienced a sharp technical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109340010","title":"Movement Alert｜PegBio Pharma Intraday Decline 15.99% in Regular Trading, Lock-Up Expiry on IPO Anniversary Triggers Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1109340010","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109340010?lang=en_us&edition=fundamental","pubTime":"2026-05-27 09:40","pubTimestamp":1779846006,"startTime":"0","endTime":"0","summary":"On May 27, PegBio Pharma (02565.HK) declined 15.99% in regular trading, trading at HK$8.78/share, with trading volume of HK$53.49 million.On the news front, May 27 marks the one-year anniversary of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107511918","title":"Stock Track | PegBio Soars 18.76% Intraday on Continued GLP-1 Drug Commercialization Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1107511918","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107511918?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:26","pubTimestamp":1779420405,"startTime":"0","endTime":"0","summary":"PegBio Co-B (02565.HK) experienced a significant intraday surge of 18.76%, continuing its recent volatile trading pattern.The stock's movement is driven by accelerating commercialization efforts for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106725922","title":"Movement Alert｜PegBio Rises 7.54% in Regular Trading, Rebounding After Pullback as GLP-1 Drug Commercialization Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1106725922","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106725922?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:25","pubTimestamp":1779420315,"startTime":"0","endTime":"0","summary":"On May 22, PegBio Co Ltd (02565.HK) rose 7.54% in regular trading, trading at HK$14.59/share with trading volume of HK$46.84 million, rebounding after a 5.14% decline in the prior session.The stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152383118","title":"Stock Track | PegBio Plummets 6.96% Intraday Amid Lock-Up Expiry Concerns Following Partnership Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1152383118","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152383118?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:07","pubTimestamp":1779329251,"startTime":"0","endTime":"0","summary":"PegBio Co-B (02565.HK) experienced a significant intraday plummet of 6.96%, continuing its recent pullback after an explosive rally earlier in the week. The decline is attributed to investor concerns...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162345639","title":"Movement Alert｜PegBio Falls 5.14% in Regular Trading, Pullback Continues Amid Lock-Up Expiry Concerns Following Multi-Day Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1162345639","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162345639?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:05","pubTimestamp":1779329149,"startTime":"0","endTime":"0","summary":"On May 21, PegBio Co Ltd (02565.HK) fell 5.14% in regular trading, trading at HK$14.38/share with trading volume of HK$29.44 million, extending a multi-day pullback after its explosive rally earlier...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161154336","title":"Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1161154336","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161154336?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:55","pubTimestamp":1779242132,"startTime":"0","endTime":"0","summary":"PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.The sustained upward momentum is driven by the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191904835","title":"Movement Alert｜PegBio Co Ltd Rises 8.37% in Regular Trading, Extending Gains on GLP-1 Drug Commercialization Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1191904835","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191904835?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:52","pubTimestamp":1779241961,"startTime":"0","endTime":"0","summary":"On May 20, PegBio Co Ltd (02565.HK) rose 8.37% in regular trading, trading at HK$17.56/share with trading volume of HK$77.81 million, extending a multi-day rally following a surge of over 100% on May...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173460761","title":"PEGBIO CO-B Nominates Liao Yilin as Independent Non-Executive Director Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1173460761","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173460761?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:48","pubTimestamp":1779191319,"startTime":"0","endTime":"0","summary":"PEGBIO Co., Ltd. - B (02565) has announced that Ms. Fan Xinpeng has tendered her resignation as Independent Non-Executive Director, Chairman of the Board Audit Committee, and member of the Board...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161","XBI","161726","BK4581","399441","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636558158","title":"Pegbio files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2636558158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636558158?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:48","pubTimestamp":1779191290,"startTime":"0","endTime":"0","summary":"PegBio filed an updated list of directors and board committee roles with the Hong Kong Stock Exchange dated May 19, 2026.Michael Min Xu remains chairman and an executive director, serving as chair of the Strategy and Development Committee.Committee leadership includes Jiancun Zhang as chair of the Remuneration and Appraisal Committee plus the Nomination Committee.Audit Committee membership includes Xiangjun Zhou plus Yangyang Chen.Other committee assignments include Xiaojun Wang on the Remuneration and Appraisal Committee, Xiangjun Zhou and Yuhong Xu on the Strategy and Development Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published the original content used to generate this news brief via IIS, the regul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL3sGZRy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176897551","title":"PegBio: INED Resignation Triggers Temporary Rule Breach; New Candidate Nominated to Restore Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1176897551","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176897551?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:44","pubTimestamp":1779191052,"startTime":"0","endTime":"0","summary":"On 19 May 2026, PegBio Co., Ltd. announced the resignation of Independent Non-Executive Director (INED) Ms. Xinpeng Fan, who also served as Chair of the Audit Committee and sat on both the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636385377","title":"PegBio independent director Fan resigns, audit committee chair role to change","url":"https://stock-news.laohu8.com/highlight/detail?id=2636385377","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636385377?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:41","pubTimestamp":1779190919,"startTime":"0","endTime":"0","summary":"PegBio disclosed the resignation of independent non-executive director Xinpeng Fan, effective May 19, 2026.Fan also stepped down as audit committee chair, with seats on the remuneration and appraisal committee, plus the nomination committee.The board nominated Liao Yik Lam as an independent non-executive director, pending shareholder approval at a general meeting.Liao is a partner at ZSZH  Fuson CPA Limited, with more than 20 years of experience in accounting, audit, company secretarial work, and business strategy.Upon election, Liao is set to take over as audit committee chair, with roles on the remuneration and appraisal committee and the nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL1Zlxqy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148340759","title":"Stock Track | PegBio Soars 28.96% Intraday on Exclusive GLP-1 Drug Commercialization Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1148340759","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148340759?lang=en_us&edition=fundamental","pubTime":"2026-05-19 10:21","pubTimestamp":1779157296,"startTime":"0","endTime":"0","summary":"PegBio Co-B's stock soared 28.96% during intraday trading on Tuesday, marking a significant price movement for the biopharmaceutical company.The surge appears driven by the company's recently...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104217647","title":"PEGBIO CO-B (02565) Surges 150% in Late Trading Following Exclusive Commercial Deal for Padakine in Mainland China","url":"https://stock-news.laohu8.com/highlight/detail?id=1104217647","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104217647?lang=en_us&edition=fundamental","pubTime":"2026-05-18 15:52","pubTimestamp":1779090742,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) experienced a sharp rise of 150% during late trading. At the time of reporting, the stock was up 106.97%, trading at HK$23.16 with a turnover of HK$784 million. The surge follows...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","399441","BK4581","VXUS","01477","BK1191","02565","BK1574","BK4588","BK4585","XBI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":117,"code":"91000000","status":"200"}]}}